Natco Pharma Ltd. is a leading pharmaceutical company based in India, specializing in niche medicines with a focus on Oncology and Hepatology. With a strong emphasis on research and development, Natco aims to make specialty drugs accessible globally. The company operates in both pharmaceuticals and agrochemicals sectors, with APIs being a key part of its business. Despite a high risk rating score of 33.1, Natco Pharma continues to seek growth opportunities internationally. ESG principles drive the company's sustainability and governance efforts.